Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Challenges and Opportunities in Development of Orphan Drugs for Rare and Neglected Diseases
- At: 2017 FIP Congress in Stockholm (Sweden)
- Type: Poster
- By: ADEYEYE, Moji (Roosevelt University, Biopharmaceutical Sciences, Schaumburg, United States)
- Co-author(s): Moji Adeyeye: Biopharmaceutical Sciences, Roosevelt University, Schaumburg, United States
BackgroundsDevelopment of orphan drugs for rare and neglected diseases is fraught with opportunities and challenges globally. The opportunities include incentivizing of researchers and manufacturers in fee reduction or no fees for protocol assistance, preauthorization inspections, marketing authorization, grants, and granting of market.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019